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Background
Asthma is a chronic inflammatory disease characterized by
bronchial hyper-responsiveness [1]. As the most endemic
of all childhood diseases, asthma accounts for the majority
of hospitalizations and school absences in children [2].
Exciting new research focuses on the involvement of the
gut microbiome in asthma development. Murine studies
support the hypothesis that the administration of probio-
tics or antibiotics during post-natal life alters the gut
microbiome and ultimately the asthmatic symptoms
of these mice [3-5]. This study will translate these findings
into humans using stool samples obtained from the
Canadian Healthy Infant Longitudinal Development
(CHILD) study.
Hypothesis
The composition of the human gut microbiome in
early life influences immune system development spe-
cifically related to asthma susceptibility, and specific
microbial populations protect against or promote
asthma development.
Methods
1262 children enrolled in the CHILD study with valid skin
prick test and wheeze data (determined by questionnaire/
clinical assessment) were grouped into four clinically rele-
vant phenotypes: atopic wheeze, atopic non-wheeze, non-
atopic wheeze, and non-atopic non-wheeze. Individuals
who test positive for both wheeze and atopy are known to
be at the highest risk for developing asthma versus those
of the other three phenotypes [6,7]. 16S rDNA extracted
and amplified from 3-month and 1-year stool samples of
children in these four phenotypes was subjected to high
throughput Illumina sequencing to identify common/
predominant microbial populations among these children
during the first year of life. Principle coordinate analysis
(PCoA) will be applied to compare the microbial taxa
among the four phenotypes and assess the effect of
confounding factors.
Results
PCoA will be used to compare the microbial popula-
tions among these four phenotypes. This analysis will be
extended to examine the effects of confounding factors
such as, mode of delivery, antibiotic exposure, feeding
methods (breast milk vs. formula/solid food diet), and
furred pet exposure on the gut microfloral diversity and
composition relative to asthma development. These data
will ultimately be compared alongside murine model
data already established in the Finlay lab as well as with
additional clinical data from the CHILD study regarding
asthma/allergy development in these subjects at 3- and
5-years of age.
Conclusions
This study could potentially identify the gut microbiome
as a therapeutic target to prevent the development of
asthma in children, perhaps through the addition of speci-
fic probiotic regimens during the first year of life [4].
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